Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1976 1
1986 2
1987 4
1988 3
1989 5
1990 2
1991 2
1992 1
1993 2
1996 1
1999 3
2000 1
2001 4
2002 1
2003 1
2004 3
2005 3
2006 5
2007 1
2009 5
2010 5
2011 6
2012 3
2013 1
2014 2
2015 1
2016 4
2017 3
2018 1
2019 2
2020 6
2021 5
2022 10
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study.
Rahbar K, Essler M, Pabst KM, Eiber M, Fougère C, Prasad V, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Fendler WP, Kurtinecz M, Schmall A, Verholen F, Sartor O. Rahbar K, et al. Among authors: dittmann h. J Nucl Med. 2023 Apr;64(4):574-578. doi: 10.2967/jnumed.122.264456. Epub 2022 Oct 27. J Nucl Med. 2023. PMID: 36302656 Free PMC article.
Long-term prognostic factors for PRRT in neuroendocrine tumors.
Trautwein NF, Schwenck J, Jacoby J, Reischl G, Fiz F, Zender L, Dittmann H, Hinterleitner M, la Fougère C. Trautwein NF, et al. Among authors: dittmann h. Front Med (Lausanne). 2023 Jun 9;10:1169970. doi: 10.3389/fmed.2023.1169970. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37359009 Free PMC article.
177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior 223Ra (RALU Study).
Rahbar K, Essler M, Eiber M, la Fougère C, Prasad V, Fendler WP, Rassek P, Hasa E, Dittmann H, Bundschuh RA, Pabst KM, Kurtinecz M, Schmall A, Verholen F, Sartor O. Rahbar K, et al. Among authors: dittmann h. J Nucl Med. 2023 Dec 1;64(12):1925-1931. doi: 10.2967/jnumed.123.266125. J Nucl Med. 2023. PMID: 37827838 Free PMC article.
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.
Trautwein NF, Schwenck J, Seitz C, Seith F, Calderón E, von Beschwitz S, Singer S, Reischl G, Handgretinger R, Schäfer J, Lang P, Pichler BJ, Schulte JH, la Fougère C, Dittmann H. Trautwein NF, et al. Among authors: dittmann h. Theranostics. 2024 Jan 20;14(3):1212-1223. doi: 10.7150/thno.92481. eCollection 2024. Theranostics. 2024. PMID: 38323317 Free PMC article.
First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma.
Trautwein NF, Reischl G, Seitz C, Dittmann H, Seith F, Scheuermann S, Feuchtinger T, Dombrowski F, Handgretinger R, Fuchs J, Pichler B, Fougère C, Schwenck J. Trautwein NF, et al. Among authors: dittmann h. J Nucl Med. 2023 Feb;64(2):337-338. doi: 10.2967/jnumed.122.264626. Epub 2022 Sep 15. J Nucl Med. 2023. PMID: 36109181 Free PMC article. No abstract available.
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients.
Georgi TW, Stoevesandt D, Kurch L, Bartelt JM, Hasenclever D, Dittmann H, Ferda J, Francis P, Franzius C, Furth C, Gräfe D, Gussew A, Hüllner M, Menezes LJ, Mustafa M, Stegger L, Umutlu L, Zöphel K, Zucchetta P, Körholz D, Sabri O, Mauz-Körholz C, Kluge R. Georgi TW, et al. Among authors: dittmann h. J Nucl Med. 2023 Jan;64(1):96-101. doi: 10.2967/jnumed.122.264112. Epub 2022 Jul 14. J Nucl Med. 2023. PMID: 35835583 Free PMC article.
Non-invasive estimation of split renal function from routine 68Ga-SSR-PET/CT scans.
Weissinger M, Seyfried KC, Ursprung S, Castaneda-Vega S, Seith F, von Beschwitz S, Vogel J, Ghibes P, Nikolaou K, la Fougère C, Dittmann H. Weissinger M, et al. Among authors: dittmann h. Front Med (Lausanne). 2023 Jun 28;10:1169451. doi: 10.3389/fmed.2023.1169451. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37448797 Free PMC article.
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P. Greulich S, et al. Among authors: dittmann h. JACC Cardiovasc Imaging. 2022 Mar;15(3):445-456. doi: 10.1016/j.jcmg.2021.08.018. Epub 2021 Oct 13. JACC Cardiovasc Imaging. 2022. PMID: 34656480 Free article.
[Clinical pathways in endocrinology and diabetology].
Gallwitz B, Lehnert H, Dittmann H, Honegger J, Teichmann R, Tatagiba M, Häring HU. Gallwitz B, et al. Among authors: dittmann h. Internist (Berl). 2006 Jul;47(7):707-10, 711-2. doi: 10.1007/s00108-006-1649-0. Internist (Berl). 2006. PMID: 16733715 Review. German.
107 results